Capricor Therapeutics, Inc. (CAPR)
6.81
+0.52
(+8.27%)
USD |
NASDAQ |
Aug 24, 16:00
6.80
-0.01
(-0.15%)
After-Hours: 20:00
Capricor Therapeutics Market Cap : 395.72M for Aug. 24, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Market Cap Data
| Date | Value |
|---|---|
| August 21, 2026 | 365.51M |
| August 20, 2026 | 397.18M |
| August 19, 2026 | 463.71M |
| August 18, 2026 | 411.41M |
| August 17, 2026 | 432.91M |
| August 14, 2026 | 386.42M |
| August 13, 2026 | 244.64M |
| August 12, 2026 | 243.48M |
| August 11, 2026 | 228.37M |
| August 10, 2026 | 223.72M |
| August 07, 2026 | 235.85M |
| August 06, 2026 | 241.04M |
| August 05, 2026 | 226.62M |
| August 04, 2026 | 240.46M |
| August 03, 2026 | 242.19M |
| July 31, 2026 | 222.01M |
| July 30, 2026 | 241.62M |
| July 29, 2026 | 378.86M |
| July 28, 2026 | 378.86M |
| July 27, 2026 | 403.36M |
| July 24, 2026 | 1.136B |
| July 23, 2026 | 1.143B |
| July 22, 2026 | 1.090B |
| July 21, 2026 | 1.141B |
| July 20, 2026 | 1.124B |
| Date | Value |
|---|---|
| July 17, 2026 | 1.121B |
| July 16, 2026 | 1.103B |
| July 15, 2026 | 1.173B |
| July 14, 2026 | 1.193B |
| July 13, 2026 | 1.188B |
| July 10, 2026 | 1.240B |
| July 09, 2026 | 1.297B |
| July 08, 2026 | 1.283B |
| July 07, 2026 | 1.281B |
| July 06, 2026 | 1.293B |
| July 02, 2026 | 1.338B |
| July 01, 2026 | 1.330B |
| June 30, 2026 | 1.389B |
| June 29, 2026 | 1.372B |
| June 26, 2026 | 1.525B |
| June 25, 2026 | 1.753B |
| June 24, 2026 | 1.702B |
| June 23, 2026 | 1.707B |
| June 22, 2026 | 1.692B |
| June 18, 2026 | 1.637B |
| June 17, 2026 | 1.612B |
| June 16, 2026 | 1.502B |
| June 15, 2026 | 1.541B |
| June 12, 2026 | 1.488B |
| June 11, 2026 | 1.444B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| REGENXBIO, Inc. | 436.56M |
| Cytokinetics, Inc. | 10.70B |
| Emergent BioSolutions, Inc. | 265.22M |
| Rigel Pharmaceuticals, Inc. | 842.50M |
| Ironwood Pharmaceuticals, Inc. | 681.61M |
Market Cap Related Metrics
| PEG Ratio | -0.0564 |
| Price to Book Value | 1.607 |
| Price | 6.81 |
| Earnings Yield | -35.97% |
| PEGY Ratio | -0.0564 |